GASTRIC (STOMACH) CANCER
Clinical trials for GASTRIC (STOMACH) CANCER explained in plain language.
Never miss a new study
Get alerted when new GASTRIC (STOMACH) CANCER trials appear
Sign up with your email to follow new studies for GASTRIC (STOMACH) CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat cancers: first human trial launches
Disease control Not yet recruitingThis early-stage trial tests a new drug called DA 3501 in people with advanced stomach or pancreatic cancers that have a specific marker (CLDN18.2). The main goals are to find the safest dose and see if the drug shrinks tumors. About 51 adults will receive the drug every three we…
Matched conditions: GASTRIC (STOMACH) CANCER
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
New hope for stomach cancer: experimental drug BHB810 enters human trials
Disease control Not yet recruitingThis study tests a new drug, BHB810, in adults with advanced stomach or gastroesophageal junction cancer that has not responded to standard treatments. The drug is given as an IV infusion every two weeks. The main goals are to check safety, find the best dose, and see if it can s…
Matched conditions: GASTRIC (STOMACH) CANCER
Phase: PHASE1, PHASE2 • Sponsor: BigHat Biosciences, Inc. • Aim: Disease control
Last updated May 16, 2026 23:46 UTC
-
Stomach cancer prevention breakthrough: targeted bacteria eradication trial launches
Prevention Not yet recruitingThis study tests whether treating specific high-risk types of H. pylori bacteria can prevent stomach cancer. About 4,800 adults aged 40 and older will be followed for up to 10 years. Researchers will compare stomach cancer rates between those who receive targeted treatment and th…
Matched conditions: GASTRIC (STOMACH) CANCER
Phase: NA • Sponsor: Fudan University • Aim: Prevention
Last updated May 16, 2026 23:49 UTC